Skip to content

Clinical Validation for SpO2 Function of Masimo INVSENSOR00069

Clinical Validation for SpO2 Function of Masimo INVSENSOR00069

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06120777
Enrollment
89
Registered
2023-11-07
Start date
2023-11-01
Completion date
2023-12-12
Last updated
2024-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

Assess the accuracy of INVSENSOR00069's peripheral oxygen saturation (SpO2) against contemporaneous measurement from arterial blood gas (ABG) analysis.

Interventions

DEVICEINVSENSOR00069

Noninvasive pulse oximeter

Sponsors

Masimo Corporation
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

Influenced by study design: * Subject is 18 to 50 years of age. * Subject weighs a minimum of 110 lbs. * Hemoglobin value ≥ 11 g/dL. * Baseline heart rate ≥ 45 bpm and ≤ 90 bpm. * Systolic blood pressure ≤ 140 mmHg and ≥ 90 mmHg and diastolic blood pressure ≤ 90 mmHg and ≥ 50 mmHg. If systolic blood pressure is lower than 100 mmHg and/or diastolic blood pressure is lower than 60 mmHg, subject passes an orthostatic blood pressure test. * CO value ≤ 3.0% FCOHb. * Subject is comfortable to read and communicate in English\*. \*This is to ensure the subject can provide informed consent (as study materials are currently available in English only) and can comply with study procedures.

Exclusion criteria

Influenced by device warning labels: * Subjects with a skin condition affecting the digits, where the sensor is applied, which would interfere with the path of light (e.g., psoriasis, vitiligo, eczema, angioma, scar tissue, burn, fungal infection, substantial skin breakdown, etc.). * Subjects with nail polish or acrylic nails on the digits where sensor needs to be applied, who opt not to remove them. * Subject has hemoglobinopathies or synthesis disorders (e.g., thalassemia, sickle cell disease). * Subject has a peripheral vascular or vasospastic disease (e.g., Raynaud's disease). Influenced by study design/environment: * Subjects who do not pass the health assessment for safe participation in the study procedures. * Difficulty inserting an intravenous line in the subject's hand or arm and/or an arterial line in the radial artery of the subject's wrist.

Design outcomes

Primary

MeasureTime frameDescription
SpO2 Accuracy of Masimo INVSENSOR000691-3 hoursThe SpO2 accuracy of Masimo INVSENSOR00069 was determined by calculating the accuracy root mean-squared (Arms) difference between the measured values (SpO2) to the reference values (SaO2) in accordance with ISO-80601-2-61. Arms= √(∑(i=1 to n) ((SpO2\_i-SaO2\_i )\^2 ))/n.

Countries

United States

Participant flow

Participants by arm

ArmCount
Masimo INVSENSOR00069
All subjects who are enrolled into the test group and participate in data collection have the Masimo INVSENSOR00069. INVSENSOR00069: Noninvasive pulse oximeter
36
Total36

Baseline characteristics

CharacteristicMasimo INVSENSOR00069
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
36 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
5 Participants
Race (NIH/OMB)
Black or African American
11 Participants
Race (NIH/OMB)
More than one race
2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
5 Participants
Race (NIH/OMB)
White
13 Participants
Region of Enrollment
United States
36 participants
Sex: Female, Male
Female
15 Participants
Sex: Female, Male
Male
21 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 86
other
Total, other adverse events
9 / 86
serious
Total, serious adverse events
0 / 86

Outcome results

Primary

SpO2 Accuracy of Masimo INVSENSOR00069

The SpO2 accuracy of Masimo INVSENSOR00069 was determined by calculating the accuracy root mean-squared (Arms) difference between the measured values (SpO2) to the reference values (SaO2) in accordance with ISO-80601-2-61. Arms= √(∑(i=1 to n) ((SpO2\_i-SaO2\_i )\^2 ))/n.

Time frame: 1-3 hours

Population: 10 subjects not analyzed due to incorrect sensor 3 subjects not analyzed due to not desaturating to the lowest bin (70-80%)

ArmMeasureValue (NUMBER)
Masimo INVSENSOR00069SpO2 Accuracy of Masimo INVSENSOR000691.72 % of oxygen saturated hemoglobin

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026